Nadifloxacin
規格
124858-35-1CAS番号
638-863-6EC番号
7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acidIUPAC名
C19H21FN2O4化学式
360.4 g/mol分子量
nadifloxacin; 124858-35-1; jinofloxacin; Acuatim; OPC-7251; Nadifloxacine; Nadixa; Opc 7251; Nadifloxacino; Nadifloxacinum; DTXSID5046483; 6CL9Y5YZEQ; NSC-759622; NDFX; CHEBI:31889; 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-; DTXCID3026483; 1H,5H-Benzo(ij)quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (+-)-; 1H,5H-Benzo(ij)quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-; 7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid; 7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo(7.3.1.05,13)trideca-2,5,7,9(13)-tetraene-3-carboxylic acid; 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid; RefChem:831679; D10AF05; S-Nadifloxacin; MFCD00865081; C19H21FN2O4; 9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid; 9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid; OPC7251; NCGC00164620-01; Nadifloxacine [INN-French]; Nadifloxacinum [INN-Latin]; Nadifloxacino [INN-Spanish]; CCRIS 4066; CAS-124858-35-1; SR-05000001516; UNII-6CL9Y5YZEQ; Nadoxin; Nadifloxacin [INN:BAN:JAN]; Acuatim (TN); NadifloxacinOPC7251; Nadifloxacin (JAN/INN); NADIFLOXACIN [MI]; NADIFLOXACIN [INN]; NADIFLOXACIN [JAN]; SCHEMBL36593; NADIFLOXACIN [MART.]; MLS002154166; NADIFLOXACIN [WHO-DD]; CHEMBL363449; orb1226680; orb1308551; SCHEMBL29429713; GTPL12919; MSK5734; HMS2090D11; HMS2098O22; HMS2233D22; HMS3373H17; HMS3651J22; HMS3715O22; HMS5081A16; Pharmakon1600-01502312; HY-B0506; MSK5734-1000DM; Tox21_112239; BDBM50475222; MSK5734-100M; NSC759622; s3105; AKOS015895271; MSK5734-1000M; Tox21_112239_1; AC-4283; AF26117; CCG-213817; DB12447; KS-1210; NSC 759622; SB17161; NCGC00164620-02; (+-)-9-Fluoro-6,7-dihydro-8-(4-hydroxypiperidino)-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid; SMR001233465; SY053145; DB-041783; N0931; Nadifloxacin Solution in Methanol, 100ug/mL; NS00002824; SW199586-2; Nadifloxacin Solution in Methanol, 1000ug/mL; D01147; AB00918517-07; AB00918517_08; AB00918517_09; F794541; Q426605; Nadifloxacin Solution in DMSO/Methanol, 1000ug/mL; SR-05000001516-1; SR-05000001516-3; BRD-A24397426-001-09-6; BRD-A24397426-001-10-4; (+/-)-9-FLUORO-6,7-DIHYDRO-8-(4-HYDROXYPIPERIDINO)-5-METHYL-1-OXO-1H,5H-BENZO(IJ)QUINOLIZINE-2-CARBOXYLIC ACID; 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (+/-)-; 7-fluoro-8-(4-hydroxy-1-piperidyl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid; 7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.0^{5,13}]trideca-2,5(13),6,8-tetraene-3-carboxylic acid; 8-(4-hydroxy-1-piperidyl)-9-fluoro-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid; 9-Fluoro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic Acid; 9-Fluoro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic Acid; 9-fluoro-8-(4-hydroxy-1-piperidyl)-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid; 9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylicacid別名
